U.S. Health Secretary Robert F. Kennedy Jr. reignited vaccine controversy this week by repeating debunked claims about the MMR (Measles, Mumps, Rubella) vaccine during a growing measles outbreak, one of the worst in 25 years. Kennedy alleged that the vaccine contains cells from aborted fetuses and questioned the efficacy of the mumps component, sparking backlash from medical experts.
The outbreak, centered in a Mennonite community in Texas, has spread to Oklahoma, Kansas, and New Mexico, infecting hundreds and killing two children. Scientists warn the U.S. may lose its measles elimination status, achieved in 2000, if vaccination rates continue to decline.
Kennedy, long known for promoting vaccine skepticism, claimed in a News Nation interview that religious groups avoid the MMR vaccine due to "aborted fetus debris." However, experts clarified that while the rubella component is produced using a fetal cell line from a 1960s abortion, no actual fetal cells are present in the final vaccine. These lab-grown cells have been replicated for decades and are filtered out during production, leaving only a purified, weakened virus.
According to Dr. Miriam Laufer from the University of Maryland and Dr. Paulo Verardi from the University of Connecticut, any DNA remnants in the final vaccine are negligible—measured in billionths of a gram.
Kennedy also said the mumps portion of the vaccine “doesn’t work” and lacked proper safety testing. However, the CDC reports that two doses of MMR provide about 86% protection against mumps. While immunity may wane over time, vaccinated individuals typically experience milder symptoms if infected.
The Department of Health and Human Services declined to comment on Kennedy’s statements, which many experts say undermine public trust in proven vaccine science.


RFK Jr. Faces Scrutiny Over David Geier’s HHS Role and Vaccine Review Work
EU Approves New Sanctions on Israeli Settlers and Hamas Leaders
Vanda Pharmaceuticals (VNDA) Stock Soars After FDA Approves BYSANTI for Bipolar I and Schizophrenia
Trump Weighs Renewed Military Action Against Iran Amid Strait of Hormuz Crisis
US, Japan Reaffirm Strong Currency Coordination Amid Yen Volatility
Trump Credits Belarus Prisoner Release in U.S.-Backed Swap
Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand
Delcy Rodriguez Appears at ICJ Hearing Over Venezuela-Guyana Esequibo Dispute
Israel Approves Special Military Tribunal for Hamas October 7 Attack Suspects
Hantavirus Cruise Ship Outbreak Triggers Global Health Alert
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
CDC Acting Director Urges Measles Vaccination as U.S. Cases Surge in 2026
Iran Military Readiness Intensifies After Meeting With Mojtaba Khamenei
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Arcadia Mayor Eileen Wang Pleads Guilty in China Foreign Agent Case
Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone 



